Pharmaceuticals and Medical Devices

Government Investigations

Entities operating in the health care space increasingly are targeted by the DOJ, HHS OIG, individual U.S. Attorney’s Offices, and state attorneys general, all seeking to enforce a wide range of fraud and abuse laws, such as the False Claims Act, the Anti-Kickback Act, Medicare and Medicaid regulations, the Food, Drug and Cosmetic Act, the Prescription Drug Marketing Act, the U.S. Foreign Corrupt Practices Act (FCPA), health care fraud and other criminal statutes.

We represent clients facing investigation and prosecution by state and federal authorities, including the U.S. Attorneys’ offices, state attorneys general and Congressional oversight committees. Our industry experience is the cornerstone of our white collar defense and corporate investigation practice in the health care and pharmaceutical space. Representative engagements include:

  • major pharmaceutical companies and medical device companies facing government investigations
  • health insurance providers and retail pharmacy chains facing government investigation under the False Claims Act
  • internal investigations for major pharmaceutical companies and other health care entities regarding the conduct of clinical trials, sales and marketing practices, pricing, good manufacturing practices and other issues
  • hospitals facing criminal, civil and regulatory investigations by multiple federal and state agencies.

Data protection laws have changed, so we have revised our Privacy Policy.